141
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Microwave-assisted heating: innovative use in hydrolytic forced degradation of selected drugs

ORCID Icon & ORCID Icon
Pages 205-220 | Received 21 Feb 2017, Accepted 06 Jul 2017, Published online: 17 Aug 2017

References

  • Amasa SR, Arava VR, Subha M. 2014. Acid catalyzed stability studies on atomoxetine, fluoxetine and nisoxetine. Scholars Res Library. 6:312–316.
  • Barbosa F, Mantovani L, Garcia CV, Mendez AS. 2012. Studies on paliperidone in OROS tablets: extraction procedure and chromatographic analysis. ISRN Chromatogr. 2012:1–9.
  • Belal TS, Shaalan RA, El Yazbi FA, Elonsy SM. 2013. Validated stability-indicating HPLC–DAD determination of the antihypertensive binary mixture of carvedilol and hydrochlorothiazide in tablet dosage forms. Chromatographia. 76:1707–1720.
  • Bende G, Kollipara S, Kolachina V, Saha R. 2007. Development and validation of an stability indicating RP–LC method for determination of imatinib mesylate. Chromatographia. 66:859–866.
  • Bhagwate S, Gaikwad N. 2013. Stability Indicating HPLC method for the determination of hydrochlorothiazide in pharmaceutical dosage form. J Appl Pharm Sci. 3:88–92.
  • Bhattacharyya I, Basak S, Maity A, Ghosh S. 2015. Isolation and characterization of acid and base degradation products in atenolol and hydrochlorothiazide and a validated selective stability-indicating HPLC–UV method for their quantification. Int J Adv Pharm Anal. 5:36–41.
  • Bhaumik P, Mehul G, Kartik V, Rashmin P, Mrunali P. 2014. Stability indicating liquid chromatographic method for estimation of trihexyphenidyl hydrochloride and risperidone in tablet formulation: development and validation consideration. Chromatogr Res Int. 2014:1–5.
  • Bindu KH, Dhekale NH, Suryanarayana M, Anjaneyulu Y. 2012. A validated stability indicating UPLC method for simultaneous determination of assay, related substances, and degradation products of paliperidone palmitate active pharmaceutical ingredient and its pharmaceutical injection forms. J Liq Chromatogr Relat Technol. 35:533–546.
  • Bindu KH, Reddy IU, Anjaneyulu Y, Suryanarayana M. 2012. A stability-indicating ultra-performance liquid chromatographic method for estimation of related substances and degradants in paliperidone active pharmaceutical ingredient and its pharmaceutical dosage forms. J Chromatogr Sci. 50:368–372.
  • Bundgaard H, Nørgaard T, Nielsen NM. 1988. Photodegradation and hydrolysis of furosemide and furosemide esters in aqueous solutions. Int J Pharm. 42:217–224.
  • Caddick S. 1995. Microwave assisted organic reactions. Tetrahedron. 51:10403–10432.
  • Chauhan PP, Patel DY, Shah SK. 2016. Optimization of stability indicating RP-HPLC method for the estimation of an antidepressant agents alprazolam and imipramine in pure & pharmaceutical dosage form. Eurasian J Anal Chem. 11:103–113.
  • Chhabda PJ. 2013. Development and validation of stability indicating method for determination of lurasidone in bulk drug and pharmaceutical dosage form by HPLC. Int J Pharm Res Dev. 5:103–114.
  • Da Silva FEB, Kaefer CL, Becker N, Barbosa S, Picolotto RS, Barin JS, Flores ÉMM. 2013. Innovative use of microwave radiation in forced degradation of azol pharmaceutical. Rev Bras Farm. 94:265–272.
  • De Diego M, Soto J, Mennickent S. 2014. Stability-indicating LC method for the simultaneous determination of lisinopril and hydrochlorothiazide. J Chromatogr Sci. 52:1193–1197.
  • Dedania ZR, Dedania RR, Sheth NR, Patel JB, Patel B. 2011. Stability indicating HPLC determination of Risperidone in bulk drug and pharmaceutical formulations. Int J Anal Chem. 2011:1–6.
  • Dhaneshwar SR, Mahadik MV, Kulkarni MJ. 2008. Column liquid chromatography-ultraviolet and column liquid chromatography/mass spectrometry evaluation of stress degradation behavior of escitalopram oxalate. J AOAC Int. 92:138–147.
  • El-Sherif ZA, El-Zeany B, El-Houssini OM. 2005. High performance liquid chromatographic and thin layer densitometric methods for the determination of risperidone in the presence of its degradation products in bulk powder and in tablets. J Pharm Biomed Anal. 36:975–981.
  • Ghanekar A, Gupta VD, Gibbs CW. 1978. Stability of furosemide in aqueous systems. J Pharm Sci. 67:808–811.
  • Gonsalves AR, Pineiro M, Martins JM, Barata PA, Menezes JC. 2010. Identification of Alprazolam and its degradation products using LC-MS-MS. Online J Org Chem. 5:128–141.
  • Hamrapurkar PD, Gadapayale KK. 2013. Optimization and validation of RP-HPLC stability indicating method for determination of olmesartan medoxomil and its degraded product. Int J Appl Sci Eng. 11:137–147.
  • Hanyšová L, Grafnetterova T, Dubovska M, Klimeš J. 2005. Development of the analytical method for LC-MS detection of unknown degradation product of Alprazolam. Chem Papers. 59:99–102.
  • Hitscherich ME, Rydberg EM, Tsilifonis DC, Daly RE. 1987. Simultaneous determination of hydrochlorothiazide and propranolol hydrochloride in tablets by high-performance liquid chromatography. J Liq Chromatogr. 10:1011–1021.
  • Huidobro A, Rupérez F, Barbas C. 2007. Isolation, identification and determination of the major degradation product in alprazolam tablets during their stability assay. J Pharm Biomed Anal. 44:404–413.
  • International Conference of Harmonization. 2003. Stability testing of new drug substances and products. Geneva: IFPMA. ( Q1A (R2) 2003).
  • Jadhav SA, Landge SB, Choudhari PM, Solanki PV, Bembalkar SR, Mathad VT. 2011. Stress degradation behavior of paliperidone, an antipsychotic drug, and development of suitable stability-indicating RP-LC method. Chromatogr Res Int. 2011:1–10.
  • Jain P, Chaudhari A, Surana S. 2012. Development and validation of stability-indicating RP-HPLC method for determination of Olmesartan medoxomile in pharmaceutical dosage form and identification, characterization of alkaline degradation impurity of Olmesartan medoxomile drug substance as well as drug product. Chem Ind Chem Eng Quart/CICEQ. 18:595–604.
  • Joshi S, Nahire R, Shastri N, Surendranath K, Satish J. 2012. Validated stability-indicating RP-HPLC UV method for simultaneous determination of metformin and repaglinide. Acta Chromatogr. 24:419–432.
  • Kakde RB, Satone DD, Gadapayale KK, Kakde MG. 2013. Stability-indicating RP-HPLC method for the simultaneous determination of escitalopram oxalate and clonazepam. J Chromatogr Sci. 51:490–495.
  • Kurmi M, Kumar S, Singh B, Singh S. 2014. Implementation of design of experiments for optimization of forced degradation conditions and development of a stability-indicating method for furosemide. J Pharm Biomed Anal. 96:135–143.
  • Lidström P, Tierney J, Wathey B, Westman J. 2001. Microwave assisted organic synthesis – a review. Tetrahedron. 57:9225–9283.
  • Madhavi A, Reddy G, Suryanarayana M, Naidu A. 2008. Development and validation of a new analytical method for the determination of related components in tolterodine tartarate using LC. Chromatographia. 68:399–407.
  • Mahajan AA, Thaker AK, Mohanraj K. 2012. LC, LC-MS/MS studies for the identification and characterization of degradation products of hydrochlorothiazide and establishment of mechanistic approach towards degradation. J Braz Chem Soc. 23:445–452.
  • Mukhopadhyay S, Kadam K, Sawant L, Nachane D, Pandita N. 2011. Simultaneous determination of related substances of telmisartan and hydrochlorothiazide in tablet dosage form by using reversed phase high performance liquid chromatographic method. J Pharm Bioall Sci. 3:375–383.
  • Nalwade S, Ranga Reddy V, Durga Rao D, Koteswara Rao I. 2011. Rapid simultaneous determination of telmisartan, amlodipine besylate and hydrochlorothiazide in a combined poly pill dosage form by stability-indicating ultra-performance liquid chromatography. Sci Pharm. 79:69–84.
  • Patel SK, Patel NJ. 2010. Development and validation of a stability-indicating RP-HPLC method for determination of atomoxetine hydrochloride in tablets. J AOAC Int. 93:1207–1214.
  • Pathak A, Rajput SJ. 2008. Development of a stability-indicating high-performance liquid chromatographic method for the simultaneous determination of alprazolam and sertraline in combined dosage forms. J AOAC Int. 91:1344–1353.
  • Patil K, Rane V, Sangshetti J, Yeole R, Shinde D. 2010. Stability indicating LC method for the simultaneous determination of amlodipine and olmesartan in dosage form. J Chromatogr Sci. 48:601–606.
  • Prajapati DK, Dave JB, Patel CN. 2015. Microwave assisted comparative forced degradation study of oral Cephalosporin drugs using quality by design (QbD) approach and stability indicating RP-HPLC analysis. World J Pharm Pharmaceut Sci. 4:1714–1727.
  • Prekodravac B, Damm M, Kappe CO. 2011. Microwave-assisted forced degradation using high-throughput microtiter platforms. J Pharm Biomed Anal. 56:867–873.
  • Ram VR, Dave PN, Joshi HS. 2012. Development and validation of a stability-indicating HPLC assay method for simultaneous determination of spironolactone and furosemide in tablet formulation. J Chromatogr Sci. 50:721–726.
  • Raman B, Sharma BA, Ghugare PD, Nandavadekar S, Singh D, Karmuse PK, Kumar A. 2010. Structural elucidation of process-related impurities in escitalopram by LC/ESI-MS and NMR. J Pharm Biomed Anal. 53:895–901.
  • Rane V, Patil K, Sangshetti J, Yeole R, Shinde D. 2010. Stability indicating LC method for simultaneous determination of irbesartan and hydrochlorothiazide in pharmaceutical preparations. J Chromatogr Sci. 48:595–600.
  • Rao CK, Kumar KK, VijayaLaxmi M, Srinivasulu P, Madhusudhan G, Mukkanti K, Srinivas KSV. 2012. Development and validation of stability indicating LC method for olmesartan medoxomil. Am J Anal Chem. 3:153–160.
  • Reddy KK, Babu JM, Mathad VT, Eswaraiah S, Reddy MS, Dubey P, Vyas K. 2003. Impurity profile study of repaglinide. J Pharm Biomed Anal. 32:461–467.
  • Sawant SD, Barge VU. 2013. Identification and characterization of forced degradation products of paliperidone using LC–APCI–Ion Trap–MS. J Pharm Res. 6:39–47.
  • Schou-Pedersen AMV, Østergaard J, Cornett C, Hansen SH. 2015. Evaluation of microwave oven heating for prediction of drug–excipient compatibilities and accelerated stability studies. Int J Pharm. 485:97–107.
  • Shaalan RA, Belal TS, El Yazbi FA, Elonsy SM. 2013. Validated stability-indicating HPLC-DAD method of analysis for the antihypertensive triple mixture of amlodipine besylate, valsartan and hydrochlorothiazide in their tablets. Arabian J Chem. 10:1381–1394.
  • Sharma D, Srinivas KS, Gupta P, Dwivedi DP, Dureja H, Nagpal M, Rakha P, Goyal S. 2010. Simultaneous estimation of risperidone, olanzapine and quetiapine and their degradation products by HPLC. Acta Pharm Sci. 52:345–352.
  • Sharma MC, Sharma S. 2011. Stability indicating RP-HPLC method for determination and validation of repaglinide in pharmaceutical dosage form. Int J ChemTech Res. 3:210–216.
  • Soliman S, El-Agizy H, El Bayoumi A. 2014. Validated stability-indicating UPLC and derivative synchronous fluorescence spectroscopy methods for the determination of atomoxetine hydrochloride in pharmaceutical preparation. Pharm Anal Acta. 5:1–9.
  • Sonawane S, Gide P. 2011. Optimization of forced degradation using experimental design and development of a stability-indicating liquid chromatographic assay method for rebamipide in bulk and tablet dosage form. Sci Pharm. 79:85–96.
  • Sonawane S, Gide P. 2013. Study on approaches to expedite and simplify forced degradation of eplerenone. J Liq Chromatogr Relat Technol. 36:2156–2165.
  • Suneetha A, Manasa K, Sindhura SL. 2015. Stability indicating RP-HPLC method for determination and validation of lurasidone HCL in bulk and pharmaceutical dosage forms. J Pharm Res. 14:15–19.
  • Suthar A, Dubey S, Patel S, Shah A. 2009. Determination of risperidone and forced degradation behavior by HPLC in tablet dosage form. Int J PharmTech Res. 1:568–574.
  • Svirskis D, Travas-Sejdic J, Garg S. 2011. A stability indicating HPLC method for the determination of electrochemically controlled release of risperidone. J Chromatogr Sci. 49:780–785.
  • Talluri MK, Dharavath S, Kalariya PD, Prasanth B, Srinivas R. 2015. Structural characterization of alkaline and oxidative stressed degradation products of lurasidone using LC/ESI/QTOF/MS/MS. J Pharm Biomed Anal. 105:1–9.
  • Tomar RS, Joseph T, Murthy A, Yadav D, Subbaiah G, Reddy KK. 2004. Identification and characterization of major degradation products of risperidone in bulk drug and pharmaceutical dosage forms. J Pharm Biomed Anal. 36:231–235.
  • Trivedi P, Kartikeyan C, Kachave R, Bhadane R. 2009. Stability-indicating assay method for estimation of olmesartan medoxomil and its metabolite. J Liq Chromatogr Relat Technol. 32:1516–1526.
  • Trivedi RK, Jain P, Patel MC, Chatrabhuji PM, Trivedi DR. 2013. A rapid, stability indicating RP-UPLC method for determination of paliperidone palmitate in a depot injectable formulation. J Appl Pharm Sci. 3:87–92.
  • Vojta J, Jedlička A, Coufal P, Janečková L. 2015. A new, rapid, stability-indicating UPLC method for separation and determination of impurities in amlodipine besylate, valsartan and hydrochlorothiazide in their combined tablet dosage form. J Pharm Biomed Anal. 109:36–44.
  • Wathey B, Tierney J, Lidström P, Westman J. 2002. The impact of microwave-assisted organic chemistry on drug discovery. Drug Discov Today. 7:373–380.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.